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Abstract  18 
Formation of Advanced Glycation End-products (AGEs) in biological systems are 19 
increased during hyperglycaemia due to higher levels of circulating glucose and carbonyl 20 
reactive species. AGEs are causative factors of common chronic diseases. Since synthetic 21 
AGE-inhibitors exert unwanted side effects and polyphenols act as potent antiglycative 22 
agents, vegetables (fruits, seeds and related by-products) are good candidates when 23 
searching for natural inhibitors. The aim of this research is to explore the suitability of a 24 
polyphenol-rich rapeseed cake extract (RCext) to decrease the formation of AGEs in an 25 
in vitro model. Different phenols, amino acids, carbohydrates, organic acids and fatty 26 
acids were identified in the RCext by GC-MS. Results confirm the high concentration of 27 
polyphenols (73.85 ± 0.64 and 86.85 ± 2.08 mg of gallic acid equivalents g-1 of RCext 28 
spray dried and freeze dried, respectively) which is correlated with the antioxidant 29 
capacity and anti-glycative activity in a dose dependent manner. Rapeseed cake extract 30 
(3.7 mg mL−1) significantly reduced the formation of free fluorescent AGEs and 31 
pentosidine up to 34.85%. The anti-glycative activity of the extract is likely to be due to 32 
the high concentration of sinapinic acid (0.108 ± 0.0043 mg g-1) in its metabolic profile, 33 
and the mechanism of action is mediated by methylglyoxal trapping. Results show a 34 
promising potential for using rapeseed cake extract as a food supplement to ameliorate 35 
the formation of AGEs. Rapeseed cake extract should therefore be considered a potential 36 
candidate for the prevention of glycation-associated complications of age-related 37 
pathologies. 38 
  39 
1. Introduction 40 
Diabetes Mellitus (DM) is a chronic endocrine disorder that has a substantial influence 41 
on the quality of life of citizens (1). In later stages, DM can lead to nephropathy, 42 
neuropathy, cardiopathy, blindness, strokes (2) and other diabetic complications (3). The 43 
number of individuals affected by DM worldwide has quadrupled between the 1980s (108 44 
million) and the year 2014 (422 million) and its prevalence has doubled to 8.5% (4). The 45 
absence or insufficient insulin production compromises the body’s ability to convert 46 
glucose to glycogen, and hence, an accumulation of high amounts of glucose in the body 47 
eventually results in hyperglycaemia (5). This procedure aids the high glucose 48 
accumulation through glycation and their products at the advanced stage process of the 49 
Maillard Reaction (MR). The initial stage of MR involves the breakdown of Amadori 50 
products to the reactive compounds deoxysones. The pH of the environment, in which 51 
the reaction occurs, affects 3-deoxysone-pathway leading to the formation of very 52 
reactive intermediates (6). The advanced stage of MR forms irreversible Maillard reaction 53 
products (MRPs), also known as Advanced Glycation End products (AGEs), which have 54 
been shown to intervene in inflammatory pathways (7-9) and result in amplified oxidative 55 
stress and inflammation (10). AGEs are also strong causative factors for other common 56 
chronic pathologies including cardiovascular disease, cancer, and degenerative disorders 57 
such as Parkinson’s and Alzheimer’s. In addition, AGEs are strongly correlated with the 58 
process of aging within individuals who have a high glucose diet (11).  59 
Polyphenols are widely known to possess good inhibition capacity against glycation and 60 
oxidation. Therefore, their potential use against AGEs is currently under intensive 61 
research (12,13). Polyphenols have been identified as beneficial inhibitors of the 62 
formation of AGEs  and escalation of degenerative disorders. These AGEs inhibitors can 63 
trap the free radicals formed in the initial stage of the MR and can protect the body from 64 
the oxidation of nucleic acids, DNA, lipids and proteins (14). They achieve this through 65 
attachment to the amino-carbonyl compound or by interfering with the Amadori product 66 
(AP) by rearranging and discontinuing the reaction (12,15). In general, it has been 67 
established that there are three key positions in the polyphenols’ structure linked to their 68 
anti-glycative activity. These are located at the ortho-3′,4′-dihydroxy in the B ring, the 69 
2,3-double bond in conjunction with the 4-oxo group in the C ring, and the presence of 70 
3-OH group in C ring and 5-OH group in the A ring (13). For instance, in the case of 71 
flavonoids and single phenols, such as sinapinic acid and 4-vinylsyringol, the hydroxyl 72 
groups in the phenyl ring have electron-donating properties and enhance the reactivity 73 
with dicarbonyl compounds since this reaction is a nucleophilic addition, thus 74 
contributing to a reduction in the formation of AGEs (9,16). Synthetic inhibitors of the 75 
MR have several dangerous side effects increasing the need to find natural inhibitors such 76 
as polyphenols from plants and seeds (17).  77 
The aim of this work is to evaluate the anti-glycative properties of the by-product of 78 
Brassica rapa L. extracted during oil production. This by-product is mainly known as 79 
rapeseed cake (RC) (18) and is used for livestock feed due to its high energy density 80 
values and low selling price (19). Its macronutrients are estimated to be approximately 81 
36% protein, 12% fat and 13% fibre (20). The main phenols present in rapeseed are 82 
sinapinic acid derivatives with its main phenolic acid accounting for 80% in the seeds 83 
(21). Currently, the protein isolated from the rapeseed cake varieties Brassica nepul L. 84 
and Brassica rapa L. have been accepted by the European Food Safety Authority (EFSA) 85 
as a novel food ingredient (22). It suggests the use of rapeseed cake for human 86 
consumption has been reconsidered in light of the fact that those varieties show low 87 
amounts of tannins (1-3 g kg−1), glucosinolates (<30 µmol g−1) and erucic acid. There is 88 
still not much information about its advantageous bioactive ingredients other than protein. 89 
Therefore, a potential use of rapeseed cake extract in the treatment against AGEs 90 
formation is investigated in this work.  91 
 92 
2. Materials & methods 93 
2.1. Materials 94 
D(+)-Glucose (GLC), bovine serum albumin (BSA), methylglyoxal (MGO, 40% aqueous 95 
solution), glyoxal (GO, 40% aqueous solution), aminoguanidine sulphate hydrate (AG), 96 
sinapinic acid (SI), Quercetin (QE), 5-methylquinoxaline (5-MQ), nitrotetrazolium blue 97 
chloride (NBT), o-phenylenediamine (OPD), heptafluorobutyric acid (HFBA), trolox (6-98 
hydroxy- 2,5,7,8-tetramethylchroman-2-carboxylic acid), 2,4,6-tris (2-pyridyl)-s-triazine 99 
(TPTZ), 2-2′-azinobis(3-ethylbenzothiazoline- 6-sulphonic acid) diammonium salt 100 
(ABTS), Folin– Ciocalteu and  standards for phenolic compounds were provided by 101 
Sigma-Aldrich (Dorset, UK). Iron (III) chloride was purchased from Panreac (Madrid, 102 
Spain). Derivatising agents methoxyamine hydrochloride and N-methyl-N-103 
trimethylsilyltrifuoroacetamide (MSTFA) were purchased from Sigma-Aldrich (Dorset, 104 
UK). Pyridine, sugars, amino acids, organic acids and polyphenols used for identification 105 
and quantification were obtained from Sigma-Aldrich (Dorset, UK). Argpyrimidine 106 
(ArgP) and pentosidine were obtained from PolyPeptide Laboratories (Strasbourg, 107 
France). Cold pressed rapeseed cake (RC) from Brassica napus L var. catana was 108 
provided by Summer Harvest© (Perthshire, UK) and stored at room temperature, inside 109 
a sealed plastic bag. 110 
2.2 Extraction of rapeseed cake extract (RCext) 111 
The milled RC pellets were ground to a fine powder in a blender and stored at 4 °C until 112 
further use. The samples were roasted at 180 °C in a Memmert (UM200) oven for 5 and 113 
10 min and weighed to determine the water loss. This step was necessary in order to 114 
denaturate the proteins and so that the material did not clog the filter in further steps. A 115 
hot steam extraction was performed on roasted RC as described by Navarini et al (23). 116 
Briefly, 15g of samples contained in a funnel-shaped filter, were extracted with the steam 117 
produced by the water (75 ml) contained in an autoclave-type aluminium kettle heated by 118 
an external source (on gas stove for 3 minutes), to force the same water upwards through 119 
the roasted sample bed. The resulting solution was centrifuged at 1940g for 10 minutes 120 
at 4°C (Joan CR231 centrifuge). Part of the supernatant was freeze-dried and used for 121 
further analysis, and another part was spray-dried to evaluate the effect of spray-drying 122 
on the total phenolic content and antioxidant activity. The spray-drying was performed 123 
using a Büchi Mini Spray Dryer B-290 using the following conditions: inlet temperature 124 
160°C, aspirator 100%, feeding pump 25%, without cleaning the nozzle and ensuring that 125 
the maximum outlet temperature was always below 80 °C. 126 
2.3 Analysis of the RCext 127 
The roasted and unroasted RC and the RCext were analysed in terms of Total Phenolic 128 
Content (TPC) and for their antioxidant activity (ABTS). While on the freeze-dried 129 
extract FRAP assays (Ferric Reducing Ability of Plasma), metabolomic profile, anti-130 
glycative capacity, direct MGO trapping capacity, and argpyrimidine and pentosidine 131 
determinations were evaluated.  132 
2.3.1 Total Phenolic Content (TPC) and antioxidant capacity  133 
The TPC was carried out using a Folin-Ciocalteu assay as previously described by 134 
Singleton and Rossi (24). TPC was determined on samples at different roasting times (0, 135 
5, and 10 min) and on spray dried and freeze-dried extract samples. The TPC levels are 136 
expressed in gallic acid eq. g−1 (mg GAE g-1) of dry matter (d.m.). Gallic acid was used 137 
as a standard to prepare the calibration curve with a concentration range between 20 and 138 
200 μg ml−1. The solutions were measured at 760 nm using an UV/VIS-139 
spectrophotometer (Thermo Scientific Genesys 10S UV–Vis Spectrophotometer).  140 
Antioxidant capacity was measured with an indirect method using 2,2-azino-bis-(3-141 
ethylbenzothiazoline-6-sulfonic acid (ABTS) reagent following the procedure of 142 
Pellegrini et al. (25), with modifications as suggested in the studies of  Ferracane et al 143 
and Graziani et al (26,27). Results were expressed in mmol Trolox equivalent antioxidant 144 
capacity (mM TEAC g-1) and referred to a calibration curve ranging from 25 to 250 μM. 145 
All determinations were performed in triplicate. 146 
The FRAP assay was carried out as previously described by Benzie et al. (28) with minor 147 
modifications. Standards of Ferrous sulphate heptahydrate were prepared at different 148 
concentrations (0.1, 0.4, 0.8 and 1 mM). The RCext was dissolved in water before 149 
analysis. The FRAP reagent solution was made by mixing 100ml acetate buffer (300mM; 150 
pH 3.6; stored at 4◦C) with 10ml ferric chloride solution, 10ml TPTZ solution (solution 151 
brought up to 10ml with HCl and stirred on heated plate at maximum 50°C before use) 152 
and 12ml distilled water and incubated in a water bath before use. The FRAP solution 153 
(1ml) was mixed with 30μl of each sample and incubated at room temperature for 4 154 
minutes. The sample was poured inside a Fischerbrand® UV semi-micro cuvette and 155 
absorbance was read at 593 nm. The FRAP reducing capacity of Fe2+ production was 156 
calculated by the formula:  157 
𝐹𝑅𝐴𝑃 = 𝑝 𝑥 (𝑎𝑏𝑠–𝑏)/𝑎 158 
where: p = dilution factor of original sample, abs = absorbance of sample at 593 nm, a = 159 
slope of the curve and b = intercept from the curve. 160 
2.3.3 GC-MS analysis 161 
Rapeseed cake extracts were derivatized prior to GC-MS analysis in order to obtain 162 
volatile and stable compounds. The analysis was carried out according to de Falco et al. 163 
(29). For this purpose, an aliquot of diluted sample was evaporated to dryness in a vacuum 164 
centrifuge (Eppendorf Concentrator 5301) and oxymated with 50 μl of methoxyamine 165 
hydrochloride (20 mg ml-1) in pyridine at 60°C for 45 min. The active hydrogens, such as 166 
OH, SH and NH, were silylated with MSTFA at 60°C for 45 min. Analyses were 167 
performed in triplicate to reduce the possible variability of samples due to extraction, 168 
derivatization and injection. Each derivatized sample was injected in a pulsed splitless 169 
mode into an Agilent-7820A GC system with 5977E MSD operating in EI mode at 70 170 
eV. The system was equipped with a 30 m x 0.25 mm id fused-silica capillary column 171 
with 0.25 μm HP-5MS stationary phase (Agilent technologies, UK). One µl of each 172 
sample was injected and the temperature was set at 270°C. Helium was used as carrier 173 
gas at a constant flow rate of 1 ml min-1. Separation of metabolites was achieved under 174 
the following temperature program: 2 min of isothermal heating at 70°C, followed by a 175 
10°C min−1 oven temperature ramp to 320°C, and a final 2 min heating at 320°C. Spectra 176 
were recorded in the mass range 50 to 800 m/z. MassHunter Qualitative Analysis B.07.00 177 
software was used to analyse both chromatograms and mass spectra. The identification 178 
was achieved by comparison with standard compounds and with spectra in National 179 
Institute of Standard and Technologies library NIST MS Search 2.2. Data were processed 180 
with the AMDIS software to deconvolute co-eluting peaks. Artefact peaks, such as peaks 181 
due to derivatising agents, were not considered in the final analysis. The quantification of 182 
separated metabolites was calculated from Total Ion Chromatography (TIC) by the 183 
computerized integrator and with standard compounds. 184 
2.3.4 Anti-Glycation Activity of Polyphenols by in vitro glycation assay with bovine 185 
serum albumin (BSA) induced by methylglyoxal (MGO) and glucose (GLC). 186 
The glycation models of BSA with MGO (BSA-MGO assay), and GLC (BSA-GLC 187 
assay) were carried out as described by Mesías et al. (30) with slight modifications. The 188 
range of concentrations of RCext and pure sinapinic acid were from 0.14 to 3.57, and 0.04 189 
to 0.77 mg mL−1, respectively. Aminoguanidine (0.07 to 0.14 mg mL−1) was used as 190 
positive control of the inhibition for the formation of fluorescent AGEs, and quercetin 191 
(0.07 to 0.14 mg mL−1) as the polyphenol of reference. The concentrations of the reactants 192 
were 0.23 mg mL-1 for MGO, 100 mg mL−1 for GLC and 10 mg mL−1 for BSA. Briefly, 193 
the mixtures (blank, control, or sample) were incubated at 37 ºC for 14 days (BSA-MGO 194 
assay) or 21 days (BSA-GLC assay) in a PBS buffer (100 mM, pH 7.4). An aliquot was 195 
taken just before incubation and stored in at -80 ºC as a control to establish the increase 196 
in fluorescence. Fluorescence (n = 4) was measured in a microplate reader (Synergy™ 197 
HT-multimode Biotek, VT, USA) with temperature control. In parallel, samples of RCext 198 
and sinapinic acid were incubated at 37 ºC for 14 days or 21 days in order to establish 199 
their intrinsic fluorescence, if any. The formation of AGEs was monitored by 200 
fluorescence with excitation/emission at 340/420 nm for BSA-MGO or BSA-GO and 201 
360/420 nm for BSA-GLC. Results were expressed as a percentage of inhibition of AGE 202 
formation, and it was calculated according to the following equation:  203 
AGE Inhibition (%) = 1 − [[(FS – FS0) / F0] × 100] 204 
where: FS = fluorescence of the system with sample,  FS0 = intrinsic fluorescence of 205 
sample, F0 = fluorescence of the system without sample. 206 
The concentration required to inhibit glycation by 50% (IC50) was calculated from the 207 
dose–response curve using the Microsoft-Excel computer software package. 208 
2.3.5 Evaluation of direct MGO trapping capacity by HPLC-DAD. 209 
Direct MGO trapping capacity was determined as described by Mesias et al. (30) after 210 
MGO conversion into the respective quinoxaline derivative (2-MQ). The range of 211 
concentrations of RCext and sinapinic acid was 0.1–2.5 mg mL−1 and 0.03–0.54 mg mL−1, 212 
respectively. The incubation was carried out at 37 °C for 168 h in PBS (100 mM, pH 7.4). 213 
Remaining MGO as its quinoxaline derivative was determined by HPLC-DAD. 214 
Chromatograms were recorded at 315 nm with the retention times of 2-MQ, and 5-MQ, 215 
4.1, and 5.6 min, respectively. The amount of unreacted MGO was calculated from the 216 
ratio of 2-MQ and 5-MQ (internal standard) as compared with the control. The percentage 217 
of inhibition of MGO was calculated with the following formula: 218 
MGO inhibition (%) = [(CTL − S) / CTL] × 100 219 
where: CTL = amount of MGO in control, S = amount of MGO in sample with the target 220 
compound for evaluation,  221 
The concentration required to trap MGO by 50% (IC50) was obtained from the dose–222 
response curves using the Microsoft-Excel computer software package. 223 
2.3.6 Determination of argpyrimidine (ArgP) by HPLC-fluorescence. 224 
The determination of ArgP formation was carried out as described by Navarro & Morales 225 
(31) after acid hydrolysis (6 M HCl for 20 h at 110ºC) of the sample treated in the BSA-226 
MGO glycation assay. Samples (10μL) were eluted onto a Mediterranean-Sea-ODS2 227 
column (250 mm × 4 mm, 5 μm; Teknokroma, Barcelona, Spain) at a flow rate of 0.8 mL 228 
min-1. The mobile phase consisted of HFBA (1 mL L−1) (solvent A) and Acetonitrile 229 
(ACN) (500 mL L−1) containing HFBA (1 mL L−1) (solvent B) using the following 230 
gradient elution: 0 min, 20% B; 25 min, 100% B; 26 min, 100% B; 27–37 min, 20% B. 231 
ArgP was detected at 335 nm and 385 nm as the excitation and emission wavelengths, 232 
respectively, and eluted at 15.1 min. Calibration was carried out in the range 0.01–0.5 μg 233 
mL−1 with  a pure standard. The analysis was carried out on a Prominence HPLC system 234 
with an RF-20A XS fluorescence detector (Shimadzu Corporation, Kyoto, Japan). 235 
2.3.7 Determination of pentosidine by HPLC-fluorescence 236 
Pentosidine was determined in samples from the BSA-Glucose glycation assay following 237 
the HPLC method described by Wilker, Chellan, Arnold, and Nagaraj (32) with minor 238 
modifications. Samples were incubated with 1.5 mL of sodium borate (0.2 M, pH 9.2) 239 
and 1 mL of sodium borohydride (1 M in 0.1 M NaOH) for 4 h at room temperature. 240 
Then, samples were hydrolysed with 5 mL of HCl (final concentration of 6 M/20 h/110ºC) 241 
and 500 µL was dried in a Speed-Vac concentrator (ThermoFisher Scientific, 242 
Courtaboeuf, France). The residue was reconstituted in 1 mL of formic acid (1 mL L−1) 243 
and the pentosidine content of the samples was measured by HPLC-fluorescence. 244 
Samples (10 µL) were eluted onto a Mediterranean-Sea-ODS2 column (250 mm x 4 mm, 245 
5 µm; Teknokroma, Barcelona, Spain) at a flow rate of 0.8 mL min−1 under gradient 246 
elution. The mobile phase consisted of HFBA (1 mL L−1) (solvent A) and acetonitrile 247 
(500 mL L−1) containing HFBA (1 mL L−1) as solvent B and the applied gradient program 248 
was as follows: 0 min, 20% B; 25 min, 100% B; 26 min, 100% B; and 27–37 min, 20% 249 
B. Pentosidine was detected at excitation and emission wavelengths of 335 and 385 nm 250 
respectively, and eluted at 15.9 min. Calibration was carried out in the range 0.0005–0.05 251 
µg mL−1 with a pure standard. 252 
 Statistical analysis 253 
Data were analysed by ANOVA using XLStat (version 2014.5.03, Addinsoft, NY). All 254 
the results were expressed as mean ± SD. Significant differences between the samples 255 
with a confidence interval of 95% were performed by using the Tukey test. The average 256 
was calculated using the results of the thermal treatment replicates and the technical 257 
replicates (at least four observations per sample). 258 
Results and discussion 259 
Total Phenolic Content and Antioxidant capacity 260 
The content of total phenols in RC unroasted and roasted, and in RCext freeze-dried and 261 
spray-dried samples is shown in Table A. Results indicated no significant differences 262 
between the 5 and 10 minutes of roasting time compared to the unroasted sample. 263 
However, 5 minutes of roasting were needed in order to guarantee a mild protein 264 
degradation for the further extraction. A significant difference was observed between 265 
freeze-dried extracts and spray-dried extracts; with the freeze-dried extract showing a 266 
higher concentration of polyphenol equivalent content. This could be explained by the 267 
thermal treatment that the product undergoes during the spray drying process.  For this 268 
reason, the freeze-dried extract was selected for the anti-glycative activity and FRAP 269 
measurements. 270 
The antioxidant capacity of the samples was determined with the ABTS assay and the 271 
results are expressed as mM TEAC g-1. The ABTS did not show any significant decrease 272 
of antioxidant capacity after 10 minutes roasting (Table A). However, the freeze-dried 273 
extracts and the spray-dried extracts showed the same antioxidant capacity (241.65 b ± 274 
0.43 and 240.94 b ± 2.01 mM TEAC g-1). The FRAP assay was determined on the freeze-275 
dried sample only because, although there was not an important loss in antioxidant 276 
activity, a significant difference was found between freeze-dried and spray-dried sample 277 
for TPC. Result showed FRAP activity of 569.87 ± 7.35 Fe2+ eq mmol g−1 d.m. 278 
GC-MS analysis 279 
Rapeseed cake extract was analysed by using gas chromatography coupled with mass 280 
spectrometry. The detected compounds, including fatty acids, amino acids, 281 
carbohydrates, organic acids and phenols, are listed in Table B with their retention time 282 
and m/z values. The total ion chromatogram of one replicate is reported in Figure 1. All 283 
metabolites were detected as trimethylsilyl derivatives by using standard compounds as 284 
references. All mass spectra were characterized by a base peak at m/z 73 due to [(CH3)3Si] 285 
group. According to other reports, sugars are present as main metabolites (Figure 2) and 286 
sucrose (Sucr) is the most abundant one (33). Other sugars identified were sorbose (Sorb), 287 
tagatose (Tag) and galactose (Gal), present in very similar amount in the rapeseed extracts 288 
(0.091; 0.090; 0.088 mg g−1 respectively), while mannitol (Man) was present in higher 289 
amounts (0.389 mg g−1). Lactic acid is the major organic acid identified, followed by 290 
benzoic acid. Sinapinic acid was identified in the metabolic profile of RCext as sinapinic 291 
acid 2 trimethylsilyl derivative (2TMS), and the quantitative analysis showed high 292 
amount of this compound (0.108 mg g-1). The main fatty acids detected were palmitic 293 
(PA) and stearic acid (ST), with a base peak at m/z 313 and 341 respectively (Table B) 294 
due to the loss of a methyl group from the TMS ester group.  295 
Glycation 296 
The anti-glycative activity of the rapeseed cake extract and standards (sinapinic acid, 297 
aminoguanidine, and quercetin) is summarized in Table C. Accumulation of AGE-298 
specific fluorescence applied in this investigation is a general measure to assess the 299 
protein glycation damage (34). The reaction was carried out at moderate conditions for 300 
14 or 21 days of incubation at 37 °C for BSA–MGO and BSA–GLC systems, 301 
respectively, in order to avoid any potential formation of artefacts when the reaction is 302 
speeded at higher temperature and shortest time. The reaction proceeded slower in the 303 
BSA-GLC since the conversion of glucose is necessary for its open-chain form and the 304 
parallel reaction of autoxidation to generate reactive dicarbonyls. In addition, the intrinsic 305 
fluorescence of samples was residual, accounting for <5 % of the total fluorescence in the 306 
glycation models. The anti-glycative capacity of samples was initially assayed in a range 307 
from 0.5 to 5 mg mL−1. However, due to the limited solubility of the RCext, the maximum 308 
effective concentration was set at 3.57 mg mL−1, and the minimum effective 309 
concentration of sinapinic acid was set at 0.04 mg mL−1 due to its high activity. Rapeseed 310 
cake extract and sinapinic acid exerted a dose dependent anti-glycation activity in BSA–311 
MGO and BSA–GLC systems in the concentration range studied (Table C). The 312 
concentration required to inhibit glycation by 50% (IC50) in the BSA-GLC was 0.36 and 313 
0.16 mg mL−1 for rapeseed cake extract and sinapinic acid, respectively. The anti-314 
glycative activity for the BSA-GLC system was nearly double for the sinapinic acid as 315 
compared with the rapeseed cake extract, but it was in the same order of magnitude. 316 
However, the anti-glycative activity of sinapinic acid in the BSA-MGO system was 317 
nearly sixteen times more effective than the RCext with values of 0.09 and 1.45 mg mL−1, 318 
respectively. The anti-glycative activity of sinapinic acid occurs mainly through the 319 
trapping of MGO which significantly reduces the formation of fluorescent AGEs in the 320 
BSA-MGO system. However, the rapeseed cake extract did not show a similar response 321 
against MGO. In both glycation models, the activity of sinapinic acid was similar to that 322 
of aminoguanidine which is used as reference, being 0.15 and 0.11 mg mL−1 for the BSA-323 
GLC and BSA-MGO system, respectively. 324 
In addition, the tentative sinapinic acid content of the RCext at the IC50 concentration was 325 
calculated to 0.157 µg mL−1. However, this value was lower than the IC50 obtained for 326 
the anti-glycative activity of pure sinapinic acid (89 µg mL−1) in the BSA-MGO system 327 
(Table C). To gain more insight into this result, the specific MGO trapping ability of 328 
rapeseed cake extract and sinapinic acid was evaluated in the range of concentration of 329 
0.1 to 2.5 mg mL−1. However, the lowest and highest effective concentration assayed for 330 
sinapinic acid was decreased to 0.03–0.54 mg mL−1, and rapeseed cake extract to 0.01 331 
due to its high reactivity. The IC50 was <0.10 and 0.095 mg mL
−1 for rapeseed cake extract 332 
and sinapinic acid for MGO trapping (Table C). This result confirms the MGO trapping 333 
capacity of both samples at simulated physiological conditions. However, the high 334 
reactivity of rapeseed cake extract against MGO does not agree with the moderate 335 
response of the extract in the BSA-MGO system as compared with sinapinic acid. 336 
Pentosidine is a protein-crosslinking fluorescent AGE that is formed in reactions of 337 
pentose with lysine and arginine, but also formed from glucose, fructose, 3-338 
deoxyglycosone or Amadori compounds, through an oxidative route (35). Rapeseed cake 339 
extract reduced up to 34.85% (at the concentration of 3.57 mg mL−1) the formation of 340 
pentosidine. Similar results were obtained for sinapinic acid, in that it was able to mitigate 341 
up to 47.09% the formation of pentosidine at the concentration of 0.77 mg mL−1 (Table 342 
D). These results are in line with those obtained for the BSA-GLC system, where both 343 
the extract and sinapinic acid exerted anti-glycation activity. However, the investigation 344 
on ArgP reveals the specific effectivity of sinapinic acid for trapping MGO. ArgP is a 345 
fluorescent AGE produced from the reaction between two molecules of MGO and 346 
arginine (36). ArgP was measured in the BSA-MGO system incubated with rapeseed cake 347 
extract and sinapinic acid in the range of 0.14-3.57 and 0.39-0.77 mg mL−1, respectively. 348 
Inhibition of ArgP (<5%) by the rapeseed cake extract was not detected, but sinapinic 349 
acid (0.77 mg mL−1) already reached an inhibition of 18.3% (Table D). These results 350 
confirm the preference of sinapinic acid to MGO that could explain its anti-glycative 351 
activity. 352 
In contrast, the anti-glycative activity exerted by rapeseed cake extract is not only due to 353 
the MGO-trapping capacity but other variables are should be further considered. The 354 
coexistence of anti- and pro-glycative compounds in the extract was observed from the 355 
GC-MS analysis. Sorbose and tagatose are reducing monosaccharides which differ in the 356 
position of hydroxyl groups, could participate in the glycation as promoters. However, 357 
they have had a great deal of attention in recent years due to their health benefits and 358 
similar properties to sucrose. In particular, the sweetness of tagatose is 92% that of 359 
sucrose but it has no glycaemic effect (37). Later on, Lu et al. (38) also demonstrated that 360 
the increase of blood glucose after the ingestion of sucrose is reduced by tagatose. In 361 
addition, a more recent study showed that sorbose could be used as a sweetener to 362 
suppress the postprandial elevation of blood levels of glucose and insulin and for the 363 
prevention of lifestyle-related diseases, such as type 2 diabetes mellitus (39). 364 
Conclusion 365 
The research investigated the anti-glycative effect of a freeze-dried rapeseed cake extract 366 
compared to sinapinic acid, the major phenolic compound in the extract. The use of spray-367 
drying as alternative processing to freeze-dried was also considered, but results did not 368 
show a significant difference in the antioxidant capacity, except in the TPC. The content 369 
of sinapinic acid in the rapeseed cake obtained by freeze-drying was higher than those 370 
obtained by spray-drying. The sinapinic acid exerted a positive effect for trapping of 371 
MGO in both BSA–MGO and BSA–GLC glycation systems. Interestingly, the sinapinic 372 
acid showed a specific activity against protein crosslinking by the inhibition of the 373 
formation of pentosidine. However, the results for the anti-glycative activity of the RCext 374 
were contradictory. Surprisingly, the RCext showed an excellent MGO trapping capacity 375 
in the BSA-GLC glycation system, but the MGO trapping activity was moderate in the 376 
BSA-MGO glycation model. The extract showed better results for the BSA-GLC 377 
glycation model than BSA-MGO where the RCext did not display an activity directly 378 
proportional to the excellent MGO trapping capacity. The RCext and sinapinic acid 379 
exerted a promising inhibitory activity against the formation of pentosidine, but only at 380 
the highest concentrations tested. In conclusion, this product could have a potential 381 
application as a food supplement in the mitigation of AGEs, but further investigation will 382 
be necessary on the removal of the pro-glycative compounds as highlighted from the GC-383 
MS analysis.  384 
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   501 
Table A. Results of total polyphenol content and antioxidant capacity on unroasted 502 
rapeseed cake and on freeze-dried and spray-dried extract. 503 
Samples 
TPC 
mg GAE g-1 
ABTS 
mM TEAC g-1 
FRAP 
Fe2+eq mmol g-1 
Unroasted 14.48a ± 0.39 95.10 a ± 12.42 
 
5' roasting 14.01a ± 1.22 89.98 a ± 8.52 
 
10' roasting 14.20a ± 1.05  78.74 a ± 5.43 
 
RCext Freeze dried 86.85c ± 2.08 241.65 b ± 0.43 569.87  ± 7.35 
RCext Spray dried  73.85b ± 0.64 240.94 b ± 2.01 
 
Significant differences were determined by ANOVA analysis and Tukey test (p ≤ 0.05). Different letters 504 
indicate significant differences. 505 
  506 
Table B. Metabolites detected by GC-MS in the rapeseed cake extract with their, 507 
abbreviation (Abb.) retention time (RT), empirical formula, mass-to-charge (m/z), and 508 
concentration (mg/g).  509 
 510 
 Metabolite  Abb. RT Formula m/z mg/g 
1 Lactic Acid, 2TMS  LA 7.25 C9H22O3Si2 219, 191, 147, 133, 117, 73, 
45 
0.139±0.001 
2 Benzoic Acid, TMS  BE 10.02 C10H14O2Si 194, 179, 135, 105, 77  0.046±0.0007 
3 Glycerol, 3TMS  GLY
C 
10.46 C12H32O3Si3 218, 205, 147, 117, 89, 73, 45 0.028±0.0006 
4 Levoglucosano, 3TMS Levo 16.37 C15H34O5Si3 333, 217, 204, 147, 129, 103, 
73 
0.047±0.001 
5 Shikimic acid Sh 17.48 C19H42O5Si4 462, 255, 204, 147, 73 0.023±0.0008 
6 Tagatose, MEOX Tag 18.38 C22H55NO6Si5 307, 217, 147, 103, 73 0.090±0.0007 
7 Sorbose, MEOX Sorb 18.47 C22H55NO6Si5 307, 217, 147, 103, 73 0.091±0.0007 
8 Galactose, MEOX Gal 18.68 C22H55NO6Si5 319, 205, 147, 103, 73 0.088±0.0009 
9 Mannitol, 6TMS  Man 19.12 C24H62O6Si6 421, 345, 319, 205, 147, 103, 
73 
0.389±0.0045 
10 Palmitic Acid, TMS  PA 19.87 C19H40O2Si 328, 313, 145, 117, 73 0.372±0.0007 
11 Myo-Inositol, 6TMS  Myo 20.70 C24H60O6Si6 305, 217, 147, 129, 73 0.261±0.007 
12 Stearic acid, TMS  ST 21.79 C21H44O2Si 356, 341, 132, 117, 73 0.521±0.0067 
13 Sinapinic acid, 2TMS  SI 21.90 C17H28O5Si2 368, 353, 338, 323, 279, 249, 
73 
0.108±0.0043 
14 Sucrose, 8TMS  Sucr 2.56 C36H86O11Si8 437, 361, 319, 271, 217, 147, 
103, 73 
9.176±0.149 
*TMS trimethylsilyl derivative 511 
**MEOX methyloxime 512 
 513 
  514 
Table C.  Summary of the antiglycative activity of rapeseed cake extracts (RCext), 515 
sinapinic acid, controls (aminoguanidine and quercetin) in the glycation assays (BSA-516 
Glucose, and BSA-Methylglyoxal), and the trapping for MGO at a fixed time reaction of 517 
168h at 37ºC. 518 
Anti-glycative activity IC50 (mg mL-1) range (mg mL-1) 
BSA-GLC glycation assay   
RCext 0.36c±0.053 0.14 – 3.57 
sinapinic acid 0.156b±0.006 0.04 – 7.71 
aminoguanidine 0.149b±0.030  
quercetin 0.054a±0.001  
   
BSA-MGO glycation assay   
RCext 1.454B±0.269 0.14 – 3.57 
sinapinic acid 0.089A±0.006 0.04 – 7.71 
aminoguanidine 0.106A±0.007  
quercetin 0.058A±0.001  
   
MGO trapping   
RCext < 0.1* 0.1 – 2.5 
sinapinic acid 0.095±0.001 0.027 – 0.54 
* Lower concentration saturates the system 519 
Different lower case letters in the results of BSA-GLC glycation assay and capital letters in the results of 520 
BSA-MGO glycation assay denote significant differences (p < 0.05). 521 
 522 
  523 
Table D. Summary of determination of argpyrimidine and determination of pentosidine 524 
on rapeseed cake extract (RCext), sinapinic acid, and controls (aminoguanidine, 525 
quercetin). 526 
 Inhibition (%) Conc. (mg mL-1) 
Argpyrimidine   
RCext * 1.43 
 * 3.57 
sinapinic acid 5.90a±4.27 0.39 
 
18.30b±6.06 0.77 
aminoguanidine 41.70c±0.22 0.14 
quercetin 24.60b±2.79 0.14 
  
   
Pentosidine   
RCext 6.26A±5.26 1.43 
 
34.85BC±8.27 3.57 
sinapinic acid 22.43AB±3.54 0.39 
 
47.09C±3.43 0.77 
aminoguanidine 10.00A±0.64 0.14 
quercetin 5.15A±1.08 0.14 
  
* not observed. Inhibition < 5% 527 
Different lower case letters in the results of inhibition of Argpyrimidine formation and capital letters in the 528 
results of inhibition of Pentosidine formation denote significant differences (p < 0.05). Sinapinic acid 529 
content of 0.154 and 0.386 µg mL-1 in the RCext of 1.43 and 3.57 mg mL-1, respectively. 530 
  531 
Figure 1. Total Ion Chromatogram (TIC) of rapeseed cake extract with detected 532 
metabolites. Numbers of metabolites as described in table B.  533 
 534 
Figure 2. Quantitative determination of detected metabolites expressed as mg g-1 of 535 
rapeseed extract. The abbreviation of each compounds is reported in Table B. 536 
 537 
Table A. Results of total polyphenol content and antioxidant capacity on crude rapeseed cake 
and on freeze-dried and spray dried extract 
Samples 
TPC 
mg GAE g-1 
ABTS 
mM TEAC g-1 
FRAP 
Fe2+eq mmol g-1 
Unroasted 14.48a ± 0.39 95.10 a ± 12.42 
 
5' roasting 14.01a ± 1.22 89.98 a ± 8.52 
 
10' roasting 14.20a ± 1.05  78.74 a ± 5.43 
 
RCext Freeze dried 86.85c ± 2.08 241.65 b ± 0.43 569.87  ± 7.35 
RCext Spray dried  73.85b ± 0.64 240.94 b ± 2.01 
 
Significant differences were determined by ANOVA analysis and Tukey test (p ≤ 0.05). Different 
letters indicate significant differences. 
  
Table B. Metabolites detected by GC-MS in the rapeseed cake extract with their retention time.  
 
 Metabolite  Abbreviation RT Formula m/z mg/g 
1 Lactic Acid, 2TMS  LA 7.25 C9H22O3Si2 219, 191, 147, 133, 
117, 73, 45 
0.139±0.001 
2 Benzoic Acid, TMS  BE 10.02 C10H14O2Si 194, 179, 135, 105, 
77 
      0.046±0.0007 
3 Glycerol, 3TMS  GLYC 10.46 C12H32O3Si3 218, 205, 147, 117, 
89, 73, 45 
0.028±0.0006 
4 Levoglucosano, 3TMS Levo 16.37 C15H34O5Si3 333, 217, 204, 147, 
129, 103, 73 
0.047±0.001 
5 Shikimic acid Sh 17.48 C19H42O5Si4 462, 255, 204, 147, 
73 
0.023±0.0008 
6 Tagatose, MEOX Tag 18.38 C22H55NO6Si5 307, 217, 147, 103, 
73 
0.090±0.0007 
7 Sorbose, MEOX Sorb 18.47 C22H55NO6Si5 307, 217, 147, 103, 
73 
0.091±0.0007 
8 Galactose, MEOX Gal 18.68 C22H55NO6Si5 319, 205, 147, 103, 
73 
0.088±0.0009 
9 Mannitol, 6TMS  Man 19.12 C24H62O6Si6 421, 345, 319, 205, 
147, 103, 73 
0.389±0.0045 
10 Palmitic Acid, TMS  PA 19.87 C19H40O2Si 328, 313, 145, 117, 
73 
0.372±0.0007 
11 Myo-Inositol, 6TMS  Myo 20.70 C24H60O6Si6 305, 217, 147, 129, 
73 
0.261±0.007 
12 Stearic acid, TMS  ST 21.79 C21H44O2Si 356, 341, 132, 117, 
73 
0.521±0.0067 
13 Sinapinic acid, 2TMS  SI 21.90 C17H28O5Si2 368, 353, 338, 323, 
279, 249, 73 
0.108±0.0043 
14 Sucrose, 8TMS  Sucr 2.56 C36H86O11Si8 437, 361, 319, 271, 
217, 147, 103, 73 
9.176±0.149 
*TMS trimethylsilyl derivative 
**MEOX methyloxime 
 
  
Table C.  Summary of Glycation (BSA-GLUCOSE, and BSA-Methylglyoxal), trapping for 
MGO at a fixed time reaction of 168h at 37ºC on rapeseed cake extracts and controls 
Anti-glycative activity IC50 (mg mL-1) range (mg mL-1) 
BSA-GLC glycation assay   
RCext 0.36c±0.053 0.14 – 3.57 
sinapinic acid 0.156b±0.006 0.04 – 7.71 
aminoguanidine 0.149b±0.030  
quercetin 0.054a±0.001  
   
BSA-MGO glycation assay   
RCext 1.454B±0.269 0.14 – 3.57 
sinapinic acid 0.089A±0.006 0.04 – 7.71 
aminoguanidine 0.106A±0.007  
quercetin 0.058A±0.001  
   
MGO trapping   
RCext < 0.1* 0.1 – 2.5 
sinapinic acid 0.095±0.001 0.027 – 0.54 
* Lower concentration saturates the system 
Different lower case letters in the results of BSA-GLC glycation assay and capital letters in the results of BSA-
MGO glycation assay denote significant differences (p < 0.05). 
 
  
Table D. Summary of determination of argpyrimidine and determination of pentosidine on 
RCext and controls 
 Inhibition (%) Conc. (mg mL-1) 
Argpyrimidine   
RCext * 1.43 
 * 3.57 
sinapinic acid 5.90a±4.27 0.39 
 
18.30b±6.06 0.77 
aminoguanidine 41.70c±0.22 0.14 
quercetin 24.60b±2.79 0.14 
  
   
Pentosidine   
RCext 6.26A±5.26 1.43 
 34.85
BC±8.27 3.57 
sinapinic acid 22.43AB±3.54 0.39 
 
47.09C±3.43 0.77 
aminoguanidine 10.00A±0.64 0.14 
quercetin 5.15A±1.08 0.14 
  
* not observed. Inhibition < 5% 
Different lower case letters in the results of inhibition of Argpyrimidine formation and capital letters in the 
results of inhibition of Pentosidine formation denote significant differences (p < 0.05). 
  
  
 
 
Figure 1. Total Ion Chromatogram (TIC) of rapeseed cake extract with detected metabolites.  
